Ceribell vs Epic Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
Ceribell (Nasdaq: CBLL) makes the only FDA-cleared AI point-of-care EEG for seizure detection in all patient ages; reported $89.1M revenue in 2025 (+36% YoY) with 2026 guidance of $111–$115M.
About
Ceribell is a commercial-stage medical technology company that has reimagined the electroencephalogram (EEG) for the acute care setting. Its flagship product is a rapid-application, disposable EEG system with an AI algorithm called Clarity that detects electrographic seizures in real time. The platform is FDA-cleared for use across all patient ages — from pre-term neonates through adults — making it the only point-of-care EEG with that breadth of clearance. In December 2025, Ceribell received additional FDA 510(k) clearance for its AI-powered delirium monitoring solution, the first and only FDA-cleared delirium screening and monitoring device.
Epic holds over 42% of U.S. acute care hospital EHR market share and is embedding AI across 150+ clinical workflows for 2026, while facing antitrust scrutiny.
About
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale electronic health record systems and reports that more than 305 million patients have a record in Epic, covering the majority of U.S. academic medical centers and large health systems including Kaiser Permanente, Mayo Clinic, Johns Hopkins, and Cleveland Clinic. Epic commands approximately 42% of U.S. acute care hospitals and nearly 55% of acute care hospital beds, making it the undisputed market leader in enterprise EHR.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.